Density Functional Theory Study of Encapsulation of an Anticancer Drug Molecule Fluorouracil (5‐FU) on M‐MOF‐74 (M = Cu and Zn) for Targeted Drug Delivery
Source abstract
Abstract
Metal–organic frameworks (MOFs) are promising candidates for drug delivery due to their high loading capacity, large surface area, stability, biodegradability, and biocompatibility. The anticancer drug fluorouracil (5‐FU) is effective but faces challenges in encapsulation and delivery. Density functional theory has been used to study the M‐MOF‐74 (M = Cu and Zn) as nanocarriers for 5‐FU. Cluster calculations (Gaussian09, WB97XD/3‐21 G*) and structure optimization (Quantum ESPRESSO, generalized gradient approximation, Perdew–Burke–Ernzerhof‐D2) reveal strong binding energies of 5‐FU on Cu and Zn‐MOFs to be 41.35 and 42.51 kcal mol −1 , respectively. Changes in the highest occupied molecular orbital–lowest unoccupied molecular orbital gaps, electrostatic potential surfaces, and charge transfer from natural bond orbital analysis indicate that both the MOFs can encapsulate 5‐FU as nanodrug carriers, suggesting potential candidates for targeted cancer therapy. Cu‐MOF‐74 has tremendous efficacy to release the drug at the targeted cancerous tissue site readily due to its strong desorption energy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Inorganic Fluorides and Related Compounds · Magnetism in coordination complexes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Central Department of Physics Tribhuvan University Kathmandu 44600 Nepal
Department of Physics Prithvi Narayan Campus Pokhara 33700 Nepal
References (45)
Show source-provided references
1. 10.1016/S1470-2045(12)70211-510.1016/S1470-2045(12)70211-5 ↗
2. 10.1038/nrc178110.1038/nrc1781 ↗
3. 10.3322/caac.2183410.3322/caac.21834 ↗
4. 10.2174/157016381266615060214431010.2174/1570163812666150602144310 ↗
5. 10.1002/adma.20160613410.1002/adma.201606134 ↗
6. 10.1016/j.mattod.2017.07.00610.1016/j.mattod.2017.07.006 ↗
7. 10.1021/acsomega.3c0835810.1021/acsomega.3c08358 ↗
8. 10.3126/hp.v10i1.5527210.3126/hp.v10i1.55272 ↗
9. 10.1021/acscentsci.7b0018610.1021/acscentsci.7b00186 ↗
10. 10.1016/j.jhazmat.2014.09.04610.1016/j.jhazmat.2014.09.046 ↗
11. 10.1517/17425247.2013.74158310.1517/17425247.2013.741583 ↗
12. 10.1016/j.jece.2020.10438610.1016/j.jece.2020.104386 ↗
13. 10.1016/j.trac.2019.06.00710.1016/j.trac.2019.06.007 ↗
14. 10.3126/hp.v9i01.4007510.3126/hp.v9i01.40075 ↗
15. 10.1039/C7QI00645D10.1039/C7QI00645D ↗
16. 10.1016/j.cbpa.2009.12.01210.1016/j.cbpa.2009.12.012 ↗
17. 10.1016/j.micromeso.2021.11097310.1016/j.micromeso.2021.110973 ↗
18. 10.1016/j.micromeso.2019.03.00210.1016/j.micromeso.2019.03.002 ↗
19. 10.1021/acsabm.3c0027510.1021/acsabm.3c00275 ↗
20. 10.1021/cm502760q10.1021/cm502760q ↗
21. 10.1002/cnma.20200022110.1002/cnma.202000221 ↗
22. 10.1039/D1RA05068K10.1039/D1RA05068K ↗
23. 10.1016/j.biopha.2013.06.00310.1016/j.biopha.2013.06.003 ↗
24. 10.1039/D0CE00409J10.1039/D0CE00409J ↗
25. 10.1103/PhysRevB.73.19510710.1103/PhysRevB.73.195107 ↗
26. 10.1063/1.47082910.1063/1.470829 ↗
27. 10.1088/0953-8984/21/39/39550210.1088/0953-8984/21/39/395502 ↗
28. 10.1016/S1093-3263(99)00028-510.1016/S1093-3263(99)00028-5 ↗
29. Frisch M. J. · 2009
30. 10.1063/1.283491810.1063/1.2834918 ↗
31. 10.3390/molecules2602042610.3390/molecules26020426 ↗
32. 10.1021/ja045123o10.1021/ja045123o ↗
33. 10.1016/j.jcat.2014.06.00610.1016/j.jcat.2014.06.006 ↗
34. 10.1016/j.jconrel.2022.05.05610.1016/j.jconrel.2022.05.056 ↗
35. Tannock I. F. · Cancer Res. · 1989 · 49 · 4373
36. Krack M. · 1996 · 297
37. Gunasekaran S. · Can. J. Anal. Sci. Spectrosc. · 2008 · 53 · 149
38. 10.1007/s00289-022-04181-710.1007/s00289-022-04181-7 ↗
39. 10.3390/ma1521742510.3390/ma15217425 ↗
40. 10.2147/IJN.S12974810.2147/IJN.S129748 ↗
41. 10.1016/j.aej.2023.03.06810.1016/j.aej.2023.03.068 ↗
42. 10.1016/B978-0-12-817650-4.00006-110.1016/B978-0-12-817650-4.00006-1 ↗
43. 10.1039/C7TB01764B10.1039/C7TB01764B ↗
44. 10.1021/acsabm.5c0083810.1021/acsabm.5c00838 ↗
45. 10.1016/j.micromeso.2017.10.03110.1016/j.micromeso.2017.10.031 ↗